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Abstract
Osteoarthritis is one of the most common chronic diseases, which have involved 250 million 
people around the world. One of the challenges in the field of cartilage tissue engineering is to 
provide an adequate source of chondrocytes to prevent changes in gene expression profile as a 
result of multiple passages.We hypothesized that by creating a low invasive lesion by scalpel or 
shear laser in the outer ear cartilage and stimulation of wound healing process, hyperplasia oc-
curs and will provide an appropriate number of autologous chondrocytes for extraction and use 
in articular cartilage tissue engineering. Also, due to the effect of platelet-rich plasma and bio-
mechanical forces in stimulating and accelerating of the repair process, these two factors can be 
used to achieve more desirable results.We describe a new approach to proliferate chondrocytes 
in the body. To evaluate this idea, various techniques of gene expression at the level of RNA or 
protein and animal experiments for histological studies can be used. Also, flowcytometry tech-
nique can be used to determine the cell viability and counting them.The use of autologous cell 
sources with minimal changes in gene expression profile can be promising in tissue engineering 
products. [GMJ.2019;8:e1483]  DOI:10.31661/gmj.v8i0.1483
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Introduction
Osteoarthritis (OA) is the most common type of arthritis that affects millions of 
people around the world. This condition oc-
curs when the protective cartilage at the end 
of the bone disappears over time. Despite the 
simple structure of cartilage tissue, it has little 
ability for repair and regeneration for reasons 
such as lack of vessels, highly differentiated 
cells, the low population density of cells, and 
slow replacement of matrix. Medical and re-
habilitation therapies such as physiotherapy 
only are useful in the early and middle stages 
of OA, but in advanced cases, only surgery 
and autologous transplantation can be per-
formed. More than one million different types 
of cartilage surgery are performed annually 
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around the world, and half of them are often 
led to the replacement of damaged cartilage 
[1-3]. Today, tissue engineering strategies 
have brought new hopes for cartilage repair. 
A lot of researches have been done on the use 
of chondrocytes in articular cartilage repair. 
As a result of problems associated with this 
cells such as lack of access, limited number, 
de-differentiation, and loss of morphology 
[4], researchers have focused on other cellu-
lar sources, such as mesenchymal stem cells 
(MSCs) [5]. However, many studies have 
shown that chondrocytes have a higher po-
tential than MSCs for the formation of hya-
line cartilage. Therefore, in many tissue engi-
neered constructs, chondrocytes are used. To 
obtain a sufficient number of chondrocytes, 
200 to 300 mg of biopsy is needed.Also, iso-
lated cells should be cultured and passaged 
at least four times–although this depends on 
the initial density [6, 7]. During culture, chon-
drocytes lose their phenotype; in other words, 
they undergo de-differentiation and get fibro-
blastic morphology. Also, their size and col-
lagen matrix secretion reduce. Microarray 
analysis identified changes in the expression 
of 137 genes in chondrocytes after two pas-
sage[8]. These changes are mainly downreg-
ulation of superficial zone protein, bone mor-
phogenetic proteins-2 (BMP-2), transforming 
growth factor-β1 (TGF-β1), fibroblast growth 
factor receptor-3, cartilage oligomeric ma-
trix protein, aggrecan, collagen II, collagen 
XI, collagen IX,SOX 9, and upregulation of 
mesenchymal or fibroblastic genes including 
collagen I, collagen X, collagen III, tenascin, 
and versican[2]. In a study, it was found that 
these changes occur within four days [9]. 
Thus with each passage, the gene expression 
profile of cells change, and these changes 
affect the formation of neocartilage. There-
fore, a method to expand chondrocytes with-
out such changes would be very helpful.The 
purpose of this article was to present an idea 
or hypothesis for the proliferation of chon-
drocytes in the patient’s body. The two main 
factors in the growth and repair of articular 
cartilage include growth factors and mechan-
ical forces [10]. Studies have shown that the 
TGF-β family, especiallyBMPs, cartilage-de-
rived morphogenetic proteins, osteogenic pro-
teins, and growth differentiation factors, have 
a significant effect on the growth and repair 
of bone and cartilage tissues [11]. In addition 
to growth factors, it has been determined that 
mechanical forces stimulate the synthesis of 
extracellular matrix proteins in vitro and in 
vivo, thus can affect the overall structure of 
the tissue. In the absence of mechanical forc-
es, tissues like cartilage are atrophied, so re-
searchers add mechanical stimuli to tissue 
engineering processes[10]. In general, tissue 
engineering processes of articular cartilage in 
ex vivo are different from other tissues, be-
cause chondrocytes require mechanical stim-
uli for differentiation. The presence of me-
chanical forces such as hydrostatic pressure or 
direct compression stimulates cells to secrete 
more extracellular matrix (ECM) compared to 
static culture. Many studies have been done 
to understand what forces are useful for the 
culture of chondrocytes, and according to 
their results, bioreactors and certain processes 
have been designed to utilize the advantage of 
mechanical stimuli. The most common biore-
actors use hydrostatic pressure and direct or 
shear pressure (caused by fluid) to stimulate 
chondrocytes[12]. Application of cyclic ten-
sile force with low frequency and low inten-
sity on chondrocytes increases the synthesis 
of proteoglycans in vitro while increasing the 
intensity and frequency of applied force has 
reverse effects and acts to degrade and reduce 
matrix synthesis [13].Also, the results showed 
that cyclic tensile force on chondrocyte cells 
up to 3% strain, 0.17 HZ and 2 hours, had no 
biological effects or had very poor respons-
es in vitro, while application of cyclic ten-
sile force between 3–10% strains, 0.17–0.5 
Hz, and 2–12 hours showed anabolic effects 
on ECM  synthesis. But cyclic tensile force 
above 10% strain, 0.5 Hz, and 12 hours apply 
destructive and catabolic effects on the ECM 
[14]. The effects of growth factors in repair of 
injuries and lesions have led to the hypothe-
sis that platelet-rich plasma (PRP), which has 
these factors, can stimulate the repair process 
in cartilage. Studies have shown that microve-
sicles and exosomes in platelets contain many 
growth factors. The most important growth 
factors in the platelets are a platelet-derived 
growth factor, TGF-β, fibroblast growth fac-
tor, insulin-like growth factor-1, connective 
tissue growth factor, epidermal growth fac-
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tor, and hepatocyte growth factor. These fac-
tors are widely used for the treatment of OA 
[15].Also, there are various micro RNAs in 
the platelets; it is said that some of them, like 
microRNA-23b,play a role in the differentia-
tion of MSCs into chondrocytes[16].Studies 
have shown that ligament healing has been in-
creased by intra-articular injection of miRNA 
210 in small animal models[17]. Also, platelet 
concentrates have anti-inflammatory proper-
ties that are critical for tissue repair, specially 
cartilage tissue[18]. Therefore, due to the ef-
fective role of growth factors and mechanical 
stimuli in the process of cartilage repair, PRP 
(as a source of growth factors) and mechan-
ical forces such as tensile stress can be used 
to stimulate the repair process in the cartilage 
tissue.
Presentation of the Hypothesis
Many researchers are looking for solutions to 
reduce changes in the gene expression pro-
file and to maintain cell phenotype of chon-
drocytes in multiple cell passages. These ap-
proaches in tissue engineering can have pos-
itive effects on the transfer of products from 
the laboratory to the clinic. We are looking 
for an approach to the proliferation of chon-
drocytes in the body to minimize changes in 
the gene expression profile and to maintain 
the chondrocyte phenotype. This approach 
can have beneficial results in the formation 
of neocartilage. For this purpose, we assumed 
that by creating a low invasive lesion in the 
outer ear cartilage, following the process of 
normal repair of the lesion, hyperplasia and an 
increase in the number of chondrocytes occur 
in the external ear cartilageso an appropriate 
number of autologous chondrocytes for use in 
cartilage tissue engineering will be provided. 
Therefore, the purpose of this hypothesis is to 
provide an acceptable number of autologous 
chondrocytes without in vitro passages for use 
in cartilage tissue engineering. Studies have 
shown that the formation of sharp cartilage le-
sions prevents widespread cell death in com-
parison with blunt lesions in the animal mod-
el. In this way, by reducing cell death, matrix 
secretion will be more effective to facilitate 
the process of integration with the surround-
ing tissue. Therefore, better repair occurs in 
sharp lesions [19, 20]. Also, by strong shear 
laser, very delicate slices can be created. Pow-
erful lasers deliver very high energy to the 
tissue, which ultimately converts to heat en-
ergy in the tissue; this heat can cause tissue 
damage and subsequently tearing or cutting 
of tissue. This laser feature is used in surgery 
to enhance the accuracy of surgery, because 
laser light can cut out the tissue like a delicate 
blade of surgery, and it helps the surgeon to do 
proper surgery in place where it is difficult to 
move surgeon’s hands or in areas where very 
thin thickness of slices are required such as 
eye surgeries, skin peeling, vascular lesions, 
laparoscopy, etc. Bleeding in laser surgery is 
very low due to the thermal coagulability of 
the laser,and the repair speed of the wound 
is also high. This speed of wound healing is 
not related to the laser’s thermal effect but de-
pends on cellular optical stimulation, which 
can cause vital activity of the cell and stim-
ulate the repair process. This laser effect is 
called biological stimulation caused by cold or 
low-energy lasers. In other words, to achieve 
this stimulating effect, it is not necessary to 
have a powerful laser [21, 22]. Therefore, to 
create a sharp lesion, according to the results 
of previous studies, a shear laser or a scalpel 
can be used to create sharp lesion.
Also, due to the important role of PRP (as a 
source of growth factors) and biomechanical 
forces (such as tensile stress with low frequen-
cy and low intensity) in repair process, these 
factors can be used to stimulate repair process 
and to achieve a more desirable outcome.
Testing the Hypothesis
To examine this hypothesis by performing an-
imal studies on dog or rabbit, nine experimen-
tal groups can be considered as follows:
1. Control
2. Creation of lesion by shear laser
3. Creation of lesion by scalpel
4. Creation of lesion by shear laser with PRP 
injection in situ
5. Creation of lesion by scalpel with PRP in-
jection in situ
6. Creation of lesion by shear laser along with 
low intensity and low frequency of tensile 
stress at the site of the lesion (between 3–10% 
strains, 0.17–0.5 Hz, and 2–12 hours)
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7. Creation of lesion by scalpel along with low 
intensity and low frequency of tensile stress at 
the site of the lesion
8. Creation of lesion by shear laser along with 
low-intensity and low frequency of tensile 
stress and PRP injection together at the site 
of the lesion
9. Creation of lesion by scalpel along with 
low-intensity and low frequency of tensile 
stress and PRP injection together at the site 
of the lesion
The effect of these factors on the process of 
repair and cartilage hyperplasia at different 
periods (4, 8, and 12 weeks after the lesion) 
and in different groups can be investigated 
by sampling from the wound site, extracting 
and counting chondrocytes (Figure-1). The 
following techniques can be used for further 
investigation and comparison of results in 
different groups with each other and with the 
control group:
1. Characterization, counting, and evaluation 
of cell viability by flow cytometry
2. Microarray analysis to determine the num-
ber and type of modified genes.
3. Examining of chondrocyte genes expres-
sion at the level of RNA or protein.
4. Histological studies
Also, by microarray analysis and examina-
tion of chondrocyte genes expression in cells 
derived from multiple passages, which is 
commonly used for the proliferation of chon-
drocytes in cartilage tissue engineering con-
structs, the results can be compared with the 
results of animal studies in the hypothesis.
Implications of the Hypothesis
This hypothesis was presented to introduce a 
suitable method for the proliferation of chon-
drocytes in the body as a live bioreactor and to 
overcome challenges in providing of adequate 
Figure 1. Presentation and testing hypothesis
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and appropriate cell sources for cartilage tis-
sue engineering and to minimize changes in 
the gene expression profile of chondrocytes. 
We hope that this hypothesis will have posi-
tive outcomes in the transferring of cartilage 
tissue engineering products to the clinic.
Conclusion
We expect to achieve a sufficient source of 
chondrocytes by creating a low invasive le-
sion in outer ear cartilage and stimulation of 
chondrocytes proliferation in the body. In this 
way, we will minimize the changes in the gene 
expression profile that occur in conventional 
methods of cell proliferation as a result of 
multiple passages.
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